Significant progress in our understanding of cancer cachexia has occurred in recent years.
Despite these advances, no pharmacologic agent has achieved US Food and Drug …

Background Metastasis of cancer causes more than 90% of cancer deaths and is severely
damaging to human health. In recent years, several studies have linked sarcopenia to …

The adverse side effect of cancer therapy on skeletal muscle has been largely ignored in the
development of cancer therapeutics. Given the extent to which loss of muscle mass and …

Investigators are increasingly measuring skeletal muscle (SM) and adipose tissue (AT)
change during cancer treatment to understand impact on patient outcomes. Recent meta …

Background The correlation between sarcopenia and hematological malignancy prognosis
is still controversial. Design: A systematic review and meta-analysis. Objectives: To explore …

Background Low muscle mass (MM) predicts unfavorable outcomes in cancer. Protein
intake supports muscle health, but oncologic recommendations are not well characterized …

Introduction Multiple screening methods for malnutrition are available, but a systematic
review of evidence in patients with colorectal cancer (CRC) is lacking. The aim of this study …

Objective To investigate the prevalence of sarcopenia and its impact on clinical outcomes in
patients with EC, GC, or CRC receiving neoadjuvant therapy through Meta-analysis …

Background Low-skeletal muscle mass (LSMM) is defined as skeletal muscle loss, which
can be assessed by imaging. Our aim was to establish the effect of LSMM on overall survival …

Background Preoperative sarcopenia in older patients is a risk factor for adverse outcomes
after colorectal cancer (CRC) surgery. Longitudinal changes in muscle mass in this group …